Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Worg Pharma Completes $57 Million Series B for Novel Allergy and Autoimmune Therapies

publication date: Sep 14, 2022

Shanghai Worg Pharma completed a $57 million Series B financing to advance clinical trials of its lead products and build its leadership team. Worg has two innovative technology platforms, both acquired from other companies, that have developed clinical-stage products: PCFiT for allergy vaccines and Apitope (antigen processing independent epitopes) that directly target the immunological basis of autoimmune diseases. In 2020, Worg closed a deal with Biomay, an Austrian company, for its PCFiT platform and its five allergy candidates. One year ago, Worg bought Apitope and its four immunotherapy candidates for autoimmune diseases. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here